Beam Therapeutics Inc (BEAM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2011 | 12-2010 | 09-2010 | 06-2010 | 03-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 269,200 | 811,500 | 671,200 | 416,300 | 289,700 |
| Receivables | 1,078,900 | 431,100 | 920,300 | 1,014,800 | 942,600 |
| Inventories | 2,171,400 | 1,523,100 | 2,109,800 | 1,960,800 | 2,052,700 |
| Other current assets | 457,300 | 1,577,300 | 469,100 | 471,800 | 498,600 |
| TOTAL | $3,976,800 | $4,343,000 | $4,170,400 | $3,863,700 | $3,783,600 |
| Non-Current Assets | |||||
| PPE Net | 1,437,200 | 668,200 | 1,403,000 | 1,406,500 | 1,449,400 |
| Investments And Advances | 0 | 51,900 | 0 | 0 | 0 |
| Intangibles | 6,793,000 | 4,364,300 | 6,653,000 | 6,547,900 | 6,762,100 |
| Other Non-Current Assets | 316,000 | 3,246,600 | 260,500 | 245,900 | 235,800 |
| TOTAL | $8,546,200 | $8,331,000 | $8,316,500 | $8,200,300 | $8,447,300 |
| Total Assets | $12,523,000 | $12,674,000 | $12,486,900 | $12,064,000 | $12,230,900 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 280,000 | N/A | 590,600 | 594,300 | 750,000 |
| Accounts payable and accrued liabilities | 486,800 | 189,300 | 491,400 | 466,100 | 465,600 |
| Other current liabilities | 851,700 | 521,000 | 915,100 | 824,000 | 782,000 |
| TOTAL | $1,675,900 | $2,106,900 | $2,020,700 | $1,937,400 | $2,054,200 |
| Non-Current Liabilities | |||||
| Long Term Debt | 3,671,300 | 3,620,600 | 3,662,900 | 3,580,600 | 3,630,800 |
| aiOther Non-Current Liabilities | 596,600 | 863,301 | 583,500 | 575,500 | 644,300 |
| TOTAL | $4,944,500 | $4,879,101 | $4,904,700 | $4,835,600 | $4,937,400 |
| Total Liabilities | $6,620,400 | $6,986,000 | $6,925,400 | $6,773,000 | $6,991,600 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 154,164 | 153,422 | 152,581 | 152,358 | 152,324 |
| Common Shares | 734,000 | 734,000 | 734,000 | 734,000 | 734,000 |
| Retained earnings | 7,550,400 | 7,499,300 | 7,416,100 | 7,373,600 | 7,175,600 |
| Other shareholders' equity | -28,600 | -150,500 | -154,800 | -362,100 | -201,000 |
| TOTAL | $5,902,600 | $5,688,000 | $5,561,500 | $5,291,000 | $5,239,300 |
| Total Liabilities And Equity | $12,523,000 | $12,674,000 | $12,486,900 | $12,064,000 | $12,230,900 |